Portfolio
2
companies
Curve Therapeutics
Curve Therapeutics develops a Microcycle platform for intracellular cancer drug discovery.
Mission Therapeutics
Mission Therapeutics discovers and develops selective inhibitors for deubiquitylating enzymes.
Denis Patrick
Managing Partner
Denis serves as a vice president at Pfizer and managing partner at Pfizer Ventures, alongside board seats across several therapeutics companies.
LinkedIn
Marie-Claire Peakman
Partner
Marie-Claire is a partner at Pfizer Ventures and an executive director at Pfizer Research and Development. She also serves on the board of directors for several therapeutics and vaccine companies.
LinkedInPfizer Ventures led the financing round alongside Columbus Venture Partners and British Patient Capital.
"This financing will enable us to expand our team, progress our lead assets into the clinic and expand our drug discovery platform. We welcome our new investors alongside our existing strong syndicate and look forward to working together to take Curve to its next stage of growth."
The financing round was led by Pfizer Ventures and accompanied by pro-rata contributions from existing investors.
"Since our initial investment in Mission seven years ago, the company has grown tremendously and the depth of its scientific expertise and capability has grown alongside it. We are proud to expand our relationship with the company and our scientists are looking forward to a successful collaboration in this important area of research."
